SCHEMBL3198488

SCHEMBL3198488

Oc1c(SBr)ccc2ccccc12

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PTPN22 Q9Y2R2 1/20 0.54
▸ LDHA P00338 1/20 0.46
▸ POLB P06746 1/20 0.45
▸ HSD17B10 Q99714 2/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ CYP2A6 P11509 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ USP2 O75604 1/20 0.44
▸ PAK1 Q13153 1/20 0.44
▸ CYP1A2 P05177 2/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ HIF1A Q16665 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2434774 0.83 PTPN22 (0.58) PTPN22LDHAPOLBHSD17B10ALDH1A1
SCHEMBL29466047 0.83 PTPN22 (0.58) PTPN22LDHAPOLBHSD17B10ALDH1A1
SCHEMBL30187599 0.83 PTPN22 (0.58) PTPN22LDHAPOLBHSD17B10ALDH1A1
SCHEMBL2233625 0.83 PTPN22 (0.58) PTPN22LDHAPOLBHSD17B10ALDH1A1
SCHEMBL6754155 0.81 PTPN22 (0.56) PTPN22LDHAPOLBHSD17B10ALDH1A1
SCHEMBL6035055 0.79 PTPN22 (0.54) PTPN22LDHAHSD17B10ALDH1A1CYP2A6
SCHEMBL11467447 0.79 PTPN22 (0.54) PTPN22LDHAHSD17B10ALDH1A1CYP2A6
SCHEMBL28572809 0.76 PTPN22 (0.50) PTPN22LDHAHSD17B10ALDH1A1CYP2A6
SCHEMBL4969506 0.76 PTPN22 (0.50) PTPN22LDHAHSD17B10ALDH1A1CYP2A6
SCHEMBL28567124 0.76 PTPN22 (0.46) PTPN22LDHAPOLBUSP2PAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7666953-B2 Phosphine-protonated haloaromatic compound accelerator with curing resin and curing agent HITACHI CHEMICAL CO, LTD. (JP) 2010-02-23 — — US disclosed
US-20090005480-A1 REACTION PRODUCT OF PHOSPHINE AND PROTONATED HALOARYL COMPOUND AND USE AS EPOXY CURING ACCELERATOR NAKAMURA SHINYA 2009-01-01 — — US disclosed
US-20050267286-A1 Curing accelerator for curing resin, curing resin composition, electronic component device and method for producing phosphine derivative HITACHI CHEMICAL CO., LTD. (JP) 2005-12-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005480-A1 REACTION PRODUCT OF PHOSPHINE AND PROTONATED HALOARYL COMPOUND AND USE AS EPOXY CURING ACCELERATOR HDHD5, EHMT2, HRH2 PTPN22 4240/4885LDHA 2160/4885POLB 369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback